CHERRICA LINDSAY: Open Payments
NPI 1750161626 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124 in 6 payments from 6 companies in 2025. Trend: 2023 $76 · 2024 $396 · 2025 $124
Food & beverage: $124
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: CAPLYTA, INVEGA SUSTENNA, Jornay PM, REXULTI, VRAYLAR, Auvelity.
Industry payments across VA — which companies pay providers there.
